Evidence map›Paper›PMID 29291930›Full record

ReviewCytokine & growth factor reviews2018

Dually modified transmembrane proteoglycans in development and disease.

Laura M Jenkins, Ben Horst, Carly L Lancaster, Karthikeyan Mythreye

Erratum issuedOpen access · greenAbstract readReview
In one paragraph

Review in Cytokine & growth factor reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Observational
  15. Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment.International journal of molecular sciences · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Heparan Sulfate Proteoglycans in Human Colorectal Cancer.Analytical cellular pathology (Amsterdam) · 2018
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Laura M JenkinsDepartment of Chemistry and Biochemistry, University of South Carolina, Columbia, SC, 29208, USA. Electronic address: Lauramj@email.sc.edu.
Ben HorstDepartment of Chemistry and Biochemistry, University of South Carolina, Columbia, SC, 29208, USA. Electronic address: Horst@email.sc.edu.
Carly L LancasterDepartment of Chemistry and Biochemistry, University of South Carolina, Columbia, SC, 29208, USA. Electronic address: carlyll@email.sc.edu.
Karthikeyan MythreyeDepartment of Chemistry and Biochemistry, University of South Carolina, Columbia, SC, 29208, USA; Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, SC, 29208, USA. Electronic address: Mythreye@sc.edu.
University of South Carolina · US

Funding

Targeting NMDA Receptors and Brain Estradiol to Rescue Memory in Aging FemalesP20GM109091 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI KIARIS, HIPPOKRATIS, RONINSON, IGOR B · 2014 to 2024
$25.2M
Inhibin function in tumor angiogenesisR01CA219495 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI KARTHIKEYAN, MYTHREYE · 2018 to 2023
$1.7M
Elucidating roles for the heparan sulfate and chondroitin sulfate glycosaminoglycan chains on Betaglycan in Wnt SignalingF31GM122379 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI LANE, LAURA MARIE · 2017 to 2018
$71k
NCI NIH HHS R01 CA219495NIGMS NIH HHS F31 GM122379NIGMS NIH HHS P20 GM109091
6 · The paper itself

Abstract

Aberrant cell signaling in response to secreted growth factors has been linked to the development of multiple diseases, including cancer. As such, understanding mechanisms that control growth factor availability and receptor-growth factor interaction is vital. Dually modified transmembrane proteoglycans (DMTPs), which are classified as cell surface macromolecules composed of a core protein decorated with covalently linked heparan sulfated (HS) and/or chondroitin sulfated (CS) glycosaminoglycan (GAG) chains, provide one type of regulatory mechanism. Specifically, DMTPs betaglycan and syndecan-1 (SDC1) play crucial roles in modulating key cell signaling pathways, such as Wnt, transforming growth factor-β and fibroblast growth factor signaling, to affect epithelial cell biology and cancer progression. This review outlines current and potential functions for betaglycan and SDC1, with an emphasis on comparing individual roles for HS and CS modified DMTPs. We highlight the mutual dependence of DMTPs' GAG chains and core proteins and provide comprehensive knowledge on how these DMTPs, through regulation of ligand availability and receptor internalization, control cell signaling pathways involved in development and disease.

Indexed as

AnimalsChondroitin SulfatesEpithelial CellsGlycosaminoglycansHeparan SulfateHumansIntercellular Signaling Peptides and ProteinsMiceNeoplasmsProteoglycansReceptors, Transforming Growth Factor betaSignal TransductionSyndecan-1Transforming Growth Factor betaWnt ProteinsbetaglycanChondroitin SulfatesGlycosaminoglycansHeparan SulfateIntercellular Signaling Peptides and ProteinsProteoglycansReceptors, Transforming Growth Factor betaSyndecan-1Transforming Growth Factor betaWnt ProteinsBetaglycanCancerCell signalingGlycosaminoglycanProteoglycanSyndecan

Identifiers

PMID29291930
PMCPMC5866756
OpenAlexW2780943676

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.